• References (3)
  • Citations (1)
Published on Jun 1, 2018in The Lancet Psychiatry18.33
Michael C. Mithoefer8
Estimated H-index: 8
(MUSC: Medical University of South Carolina),
Ann T Mithoefer4
Estimated H-index: 4
+ 8 AuthorsAmy Emerson4
Estimated H-index: 4
Summary Background Post-traumatic stress disorder (PTSD) is prevalent in military personnel and first responders, many of whom do not respond to currently available treatments. This study aimed to assess the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for treating chronic PTSD in this population. Methods We did a randomised, double-blind, dose-response, phase 2 trial at an outpatient psychiatric clinic in the USA. We included service personnel who were ...
Published on Dec 1, 2016in Journal of Psychopharmacology4.22
Stephen Ross11
Estimated H-index: 11
Anthony P. Bossis5
Estimated H-index: 5
(NYU: New York University)
+ 10 AuthorsJames S. Babb76
Estimated H-index: 76
(NYU: New York University)
Background:Clinically significant anxiety and depression are common in patients with cancer, and are associated with poor psychiatric and medical outcomes. Historical and recent research suggests a role for psilocybin to treat cancer-related anxiety and depression.Methods:In this double-blind, placebo-controlled, crossover trial, 29 patients with cancer-related anxiety and depression were randomly assigned and received treatment with single-dose psilocybin (0.3 mg/kg) or niacin, both in conjunct...
Published on Jun 23, 2015in JAMA51.27
Penny Whiting36
Estimated H-index: 36
(UoB: University of Bristol),
Robert Wolff13
Estimated H-index: 13
+ 10 AuthorsSteve Ryder8
Estimated H-index: 8
Importance Cannabis and cannabinoid drugs are widely used to treat disease or alleviate symptoms, but their efficacy for specific indications is not clear. Objective To conduct a systematic review of the benefits and adverse events (AEs) of cannabinoids. Data Sources Twenty-eight databases from inception to April 2015. Study Selection Randomized clinical trials of cannabinoids for the following indications: nausea and vomiting due to chemotherapy, appetite stimulation in HIV/AIDS, chronic pain, ...
Cited By1
Published on Apr 4, 2019in BMJ27.60
Tom P. Freeman20
Estimated H-index: 20
Chandni Hindocha10
Estimated H-index: 10
(UCL: University College London)
+ 1 AuthorsMichael A P Bloomfield8
Estimated H-index: 8
### What you need to know Until recently, cannabis and its derivatives were widely restricted under legislation which stated they had no medical value and carried a substantial risk of misuse. Policy is rapidly changing, and cannabis can now be prescribed for medicinal use in many countries, including the UK. This provides important new opportunities for treating patients although these need to be weighed up against potential risks. Several different medicinal products exist, with contrasting me...